Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neutrophil function in lymphoreticular malignancy.

R T McCormack, R D Nelson, C D Bloomfield

    Cancer
    |September 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    No evidence for microsatellite instability in acute myeloid leukemia.

    Leukemia·2017
    Same author

    The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.

    Leukemia·2017
    Same author

    Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.

    Leukemia·2016
    Same author

    Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503).

    Leukemia·2016
    Same author

    Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2.

    Leukemia·2016
    Same author

    Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia.

    The pharmacogenomics journal·2016
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Neutrophil chemotaxis showed slight impairment in untreated cancer patients but normalized after therapy. This minor defect, while not predisposing to infection alone, may contribute to compromised host defense when combined with other immune issues.

    Area of Science:

    • Immunology
    • Oncology

    Background:

    • Neutrophils play a crucial role in host defense through chemotaxis, phagocytosis, and metabolic stimulation.
    • Cancer and its treatments can potentially impact neutrophil function and patient immunity.

    Purpose of the Study:

    • To evaluate neutrophil function, specifically chemotaxis, phagocytosis, and metabolic stimulation, in patients with various malignancies.
    • To assess the impact of cancer therapy on these neutrophil functions.

    Main Methods:

    • Studied neutrophil chemotaxis, phagocytosis, and metabolic stimulation in patients with untreated lymphoreticular malignancies, untreated carcinomas, and those undergoing therapy.
    • Compared patient group functions to healthy controls.

    Main Results:

    Related Experiment Videos

  • Phagocytic activity and metabolic stimulation were comparable to controls across all patient groups.
  • Slight but significant reductions in neutrophil chemotaxis were observed in untreated patient groups compared to controls.
  • Chemotactic responsiveness largely normalized after therapy for the malignant process.

    • Conclusions:

    • Minor defects in neutrophil chemotaxis in cancer patients are unlikely to cause infection independently if immunologic function is otherwise intact.
    • These chemotactic defects could be additive, potentially contributing to compromised host defense when co-occurring with impaired immunity.